In a subcutaneous tumor-forming mouse model, when JHU083 was used to inhibit glutamine metabolism, CD8+T-cell proliferation was promoted with dampened ICI resistance, partly due to enriched exogenous lipid metabolism and lipolysis-originated ketone bodies that alternatively replenished energy stores [55,56]. This evidence concerns the gene CD8A and neoplasm.